Intensive Immunosuppressive Therapy with Umbilical Cord Blood for Severe Aplastic Anemia
Author Information
Author(s): Zhou Fang, Ge Linfu, Yu Zhe, Fang Yuan, Kong Fansheng
Primary Institution: Department of Hematology, General Hospital of Jinan Military Area, Jinan, Shandong, China
Hypothesis
To evaluate the efficacy of enhanced, intensive, immuno-suppressive therapy with umbilical cord blood support for severe aplastic anemia (SAA).
Conclusion
Enhanced, intensive, immuno-suppressive therapy with umbilical cord blood support may be an effective option for SAA therapy.
Supporting Evidence
- 18 out of 25 patients underwent a complete recovery.
- The efficacy rate was 88%.
- The 3-year overall survival rate was 92%.
- Patients rapidly achieved reconstitution of hematopoiesis.
Takeaway
Doctors treated 25 kids with a serious blood condition using special medicine and umbilical cord blood, and most of them got better quickly.
Methodology
25 patients with SAA received enhanced, intensive, immuno-suppressive therapy and a cord blood transfusion.
Limitations
Further expanded study is needed to characterize the kinetics of hematopoietic reconstitution.
Participant Demographics
Patients aged 3 to 28 years, with 12 males and 13 females.
Statistical Information
Statistical Significance
p>0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website